National Implantable Acoustic Devices Conference 2026
12 - 13 October 2026
The Great Hall, University of Birmingham
Sponsors
If you are interested in sponsoring this year's conference please contact us at academics.conferences@contacts.bham.ac.uk to explore available sponsorship packages.
Hear now. And always
Cochlear is the global leader in implantable hearing solutions providing cochlear implants and bone conduction implants. We strive to help people hear – aiming to provide them with a lifetime of hearing through the best possible support.
For more than 40 years, Cochlear has been connecting people all over the globe to the world of sound. Inspired by his father's struggles, Professor Graeme Clark developed the world’s first multi-channel cochlear implant to help treat hearing loss. Since then, Cochlear has helped more than 750,000 people of all ages to hear.
Cochlear aims to support cochlear implantation becoming the standard of care for people with severe to profound hearing loss, and offers bone conduction solutions for conductive hearing loss, mixed hearing loss and single-sided deafness.
To find out about the latest Cochlear™ Osia® System and Cochlear™ Baha® System, come to our stand.
Discover more at www.cochlear.com
MED-EL Medical Electronics, a leader in implantable hearing solutions, is driven by a mission to overcome hearing loss as a barrier to communication and quality of life. The Austrian-based, privately owned business was co-founded by industry pioneers Ingeborg and Erwin Hochmair, whose ground-breaking research led to the development of the world’s first micro-electronic multi-channel cochlear implant (CI), which was successfully implanted in 1977 and was the basis for what is known as the modern CI today. This laid the foundation for the successful growth of the company in 1990, when they hired their first employees. To date, MED-EL has more than 3,100 employees from around 90 nations and 30 locations worldwide.
The company offers the widest range of implantable and non-implantable solutions to treat all types of hearing loss, enabling people in 140 countries enjoy the gift of hearing with the help of a MED-EL device. MED-EL’s hearing solutions include cochlear and middle ear implant systems, a combined electric acoustic stimulation hearing implant system, auditory brainstem implants as well as surgical and non-surgical bone conduction devices
Oticon Medical is a global company in implantable hearing solutions, dedicated to bringing the power of sound to people at every stage of life.
We believe that patients and hearing care professionals should be able to choose the best possible solution at any time along the patient journey.
We call it “Freedom of Choice,” a principal paramount to Oticon Medical. That’s why our solutions are designed to be compatible whenever possible, reflecting unwavering lifelong support.
We work collaboratively with professionals to create solutions that enhance quality of life and help people live life to the fullest—now and in the future. Because we know how much sound matters.
Key Dates | |
|---|---|
Call for Abstracts | 13 April 2026 |
Abstracts Submission Deadline | 3 July 2026 |
Notification of Acceptance | 24 July 2026 |
Early Bird Registration Deadline | 28 August 2026 |
Late Registration Deadline | 18 September 2026 |
As part of the organisation of this conference, The University of Birmingham's Event Management Team is collecting income via registration fees and sponsorships on behalf of National Implantable Acoustic Devices Conference.